Medtronic
- Market cap
- 109.38B
- P/E (TTM)i
- 21.06
- P/Bi
- 2.18
- EPSi
- 3.73
- Div yieldi
- 3.33%
- 52W posi
- 44%
Anonymous reader poll. Unscientific, not investment advice.
About Medtronic
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
- Founded
- 2014
- CEO
- Mr. Geoffrey S. Martha
- Employees
- 95,000
- Headquarters
- Galway, GA, Ireland
- Fiscal year end
- 04-30
- Website
- medtronic.com
Company profile
- Exchange
- US
- Symbol
- MDT
- Market-cap rank
- #176
- Listing date
- 1970-01-01
- Market cap
- 109.38B
- Float cap
- 109.17B
- Shares out
- 1.28B
- Float shares
- 1.28B
Sectors & themes
Quote time 2026-10-08 08:20:02 · For reference only, not investment advice and not tailored to your situation.